Anita Knott
Head, Regulatory Affairs CMC Cell Therapy, Astellas Pharma US
I have 25 years of global Regulatory Affairs CMC experience in biologics such as cell, gene therapy and monoclonal antibodies, and transgenic products for various diseases including rare diseases.
These products ranged from clinical to commercial and leveraged acceleration regulatory pathways.